Literature DB >> 16719941

A conceptual model for the pathophysiology of vulvar vestibulitis syndrome.

Denniz Zolnoun1, Katherine Hartmann, Georgine Lamvu, Suzie As-Sanie, William Maixner, John Steege.   

Abstract

UNLABELLED: Vulvar vestibulitis syndrome (vestibulitis), the most common type of chronic vulvovaginal pain, impairs the psychologic, physical, and reproductive health of approximately 10% of women at some point in their lives. Research on the pathophysiology of vestibulitis suggests abnormalities in 3 interdependent systems: vestibular mucosa, pelvic floor muscles, and central nervous system pain regulatory pathways. To date, causes and relative contributions of these abnormalities to the development and maintenance of vestibulitis remain poorly understood. Research consistently supports the conceptualization of vestibulitis as a chronic pain disorder-akin to fibromyalgia, irritable bowel disorder, and temporomandibular disorder (TMD)-that is far more complex than vestibular hypersensitivity alone. Nevertheless, the clinical diagnosis of vestibulitis continues to rely on subjective report of pain during intercourse and vestibular sensitivity on clinical examination after exclusion of other gynecologic disorders. We propose that current diagnostic criteria, which are based on highly subjective patient and clinician measures, are not sufficient to describe and properly classify the heterogeneous clinical presentations of this disorder. To inform clinical care or research, we must be able to objectively characterize women with vestibulitis. This narrative review critically appraises current conceptualization of vestibulitis and presents a context for studying vestibulitis as a chronic pain disorder, emphasizing the need for objective assessment of clinical features. TARGET AUDIENCE: Obstetricians & Gynecologists, Family Physicians. LEARNING
OBJECTIVES: After completion of this article, the reader should be able to state that vulvar vestibulitis is common; recall that the disorder has three major pathophysiological pathways and that understanding of these pathways is important in selecting treatment options, and explain that the clinician must attempt to properly classify the clinical presentations of the disorder.

Entities:  

Mesh:

Year:  2006        PMID: 16719941     DOI: 10.1097/01.ogx.0000219814.40759.38

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  20 in total

1.  Myofascial trigger points of the pelvic floor: associations with urological pain syndromes and treatment strategies including injection therapy.

Authors:  Robert M Moldwin; Jennifer Yonaitis Fariello
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

2.  Natural history of comorbid orofacial pain among women with vestibulodynia.

Authors:  Eric Bair; Elizabeth Simmons; Jessica Hartung; Kinnari Desia; William Maixner; Denniz Zolnoun
Journal:  Clin J Pain       Date:  2015-01       Impact factor: 3.442

3.  Reliability and reproducibility of novel methodology for assessment of pressure pain sensitivity in pelvis.

Authors:  Denniz Zolnoun; Eric Bair; Greg Essick; Richard Gracely; Vinita Goyal; William Maixner
Journal:  J Pain       Date:  2012-09       Impact factor: 5.820

4.  Presenting Symptoms Among Black and White Women with Provoked Vulvodynia.

Authors:  Candace S Brown; Davis C Foster; Candi C Bachour; Leslie A Rawlinson; Jim Y Wan; Gloria Ann Bachmann
Journal:  J Womens Health (Larchmt)       Date:  2015-08-20       Impact factor: 2.681

5.  Psychosexual correlates of persistent postsurgical pain in patients with vulvodynia.

Authors:  Alisa Eanes; Eric Bair; Caitlin Martin; Priya Iyer; Denniz Zolnoun
Journal:  Int J Gynaecol Obstet       Date:  2011-04-09       Impact factor: 3.561

6.  MicroRNA expression profiles differentiate chronic pain condition subtypes.

Authors:  Brittney P Ciszek; Asma A Khan; Hong Dang; Gary D Slade; Shad Smith; Eric Bair; William Maixner; Denniz Zolnoun; Andrea G Nackley
Journal:  Transl Res       Date:  2015-06-24       Impact factor: 7.012

7.  Overlap between orofacial pain and vulvar vestibulitis syndrome.

Authors:  Denniz A Zolnoun; Jacqueline Rohl; Charity G Moore; Cara Perinetti-Liebert; Georgine M Lamvu; William Maixner
Journal:  Clin J Pain       Date:  2008 Mar-Apr       Impact factor: 3.442

8.  Open-label trial of lamotrigine focusing on efficacy in vulvodynia.

Authors:  Samantha E Meltzer-Brody; Denniz Zolnoun; John F Steege; Katherine L Rinaldi; Jane Leserman
Journal:  J Reprod Med       Date:  2009-03       Impact factor: 0.142

9.  Rationale and design of a multicenter randomized clinical trial of extended release gabapentin in provoked vestibulodynia and biological correlates of response.

Authors:  Candace S Brown; David C Foster; Jim Y Wan; Leslie A Rawlinson; Gloria A Bachmann
Journal:  Contemp Clin Trials       Date:  2013-06-29       Impact factor: 2.226

10.  Somatization and psychological distress among women with vulvar vestibulitis syndrome.

Authors:  Denniz Zolnoun; Eliza M Park; Charity G Moore; Cara A Liebert; Frank F Tu; Sawson As-Sanie
Journal:  Int J Gynaecol Obstet       Date:  2008-07-16       Impact factor: 3.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.